Traditional Chinese medicine extract for treating diabetes and preparation method

Abstract

The invention relates to a traditional Chinese medicine extract for treating diabetes. The traditional Chinese medicine extract is prepared from the following crude drugs of 8 to 12 parts of rhizoma polygonati, 8 to 12 parts of radix astragali seu hedysari, 6 to 10 parts of radix panacis quinquefolii, 8 to 12 parts of radix ophiopogonis, 18 to 22 parts of rhizoma dioscoreae, 8 to 12 parts of pueraria mirifica, 8 to 12 parts of bitter gourd, 6 to 10 parts of fructus lycii, 6 to 10 parts of rhizoma polygonati odorati, 8 to 12 parts of fructus cormi, 6 to 10 parts of mulberry fruit, 6 to 10 partsof ramuli euonymi, 8 to 12 parts of herba epimedii, 6 to 10 parts of radix rehmanniae recen, 6 to 10 parts of radix rehmanniae praeparata, 6 to 10 parts of semen cassiae, 4 to 6 parts of semen cuscutae, 2 to 4 parts of cortex cinnamomi, 6 to 8 parts of radix trichosanthis, 8 to 12 parts of cortexlycii radicis, 4 to 6 parts of banana, 8 to 12 parts of grape peel, and 8 to 12 parts of grape seed. The invention also relates to a preparation method and application of the traditional Chinese medicine extract for treating diabetes. The traditional Chinese medicine extract has the advantages that the effects of invigorating Qi and nourishing Yin as well as promoting body fluid production and relieving thirst are realized; proofed by clinical application, the good treatment function is realized on the diabetes.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine extract for treating diabetes and its preparation method and application. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by hyperglycemia caused by defects in insulin secretion or its biological effects. Long-term hyperglycemia can lead to chronic damage to various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. ,disfunction. Diabetes is divided into type 1 and type 2, of which type 2 diabetes accounts for more than 90%. For type 2 diabetes, besides insulin, most of the current clinical treatment drugs are chemical drugs such as sulfonylureas to promote the secretion of insulin by the pancreas to lower blood sugar, or biguanides to promote the utilization of glucose by peripheral tissues to achieve the effect of lowering blood sugar. Long-term injection of insulin is likely ...

AI Technical Summary

Problems solved by technology

Long-term injection of insulin is likely to cause hypoglycemia, weight gain, edema, etc.; sulfonylurea hypoglycemic drugs are more likely to cause adverse reactions such as hypoglycemia, neutropenia, and cardiovascular disease; large doses of biguanide hypoglycemic drugs can cause gastrointestinal reactions, Patients with lung, liver, and kidney lesions are prone to lactic acidosis

Therefore, the above-mentioned drugs often have drug resistance, drug resistance formation, allergic reactions and toxic effects. Although they have a quick effect, they are highly dependent and treat the symptoms but not the root cause. had to reduce or discontinue